OSINIB 80 Mg (Osimertinib)

Description

About OSINIB 80 Mg

Osimertinib 80 mg (Osinib Mesylate INN) is the active ingredient in each tablet of Osinib 80mg.. Metastatic non-small cell lung cancer (NSCLC) with the epidermal growth factor receptor T790M mutation is a valid indication for osinib (80 mg). Drug International Ltd. is the producer of this medicine.

Dosage

One 80mg tablet of Osinib should be taken orally once daily, with or without food, until the disease progresses. Osinib 80mg should be taken once daily, around the same time each day. Take this medication exactly as prescribed by your doctor for the best results.

Side Effects

• Interstitial lung disease (ILD).
• QTc interval prolongation (QTc prolongation).
• Cardiomyopathy (CM).
• Keratitis (eye inflammation).

Storage

Keep Osinib 80mg in a cool (below 30 degrees Celsius), dry place that is not directly exposed to light and out of the reach of children.